Headline;Month;Day
I Run a G.M.O. Company — and I Support G.M.O. Labeling;5;16
The Latest and Best in Crime Fiction;8;19
IndyCar Chief Looks to Build Interest Beyond the 100th Indianapolis 500;3;10
Alzheimer’s Drug LMTX Falters in Final Stage of Trials;7;27
Top Lobbyist for Drug Makers Threads a Thicket of Outrage;2;26
How Valeant Cashed In Twice on Higher Drug Prices;7;29
Brand-Name Drug Makers Wary of Letting Generic Rival Join Their Club;7;1
The Election’s Effect on the Economy? Doughnut Sales Are Probably Safe;10;31
The Top 10 Moments From Men’s Fashion Month;2;5
Ireland Doesn’t Want Apple’s Back Taxes, but the Irish Aren’t So Sure;9;11
Lives and Profits in the Balance: The High Stakes of Medical Patents;12;12
What’s on This Week Around the World;2;5
At a Loss for Meds, Venezuela’s Mentally Ill Spiral Downward;10;1
The Lives and Lies of a Professional Impostor;2;4
Drug Giant Faced a Reckoning as China Took Aim at Bribery;11;1
Could Ancient Remedies Hold the Answer to the Looming Antibiotics Crisis?;9;14
Meet the Highest-Paid C.E.O.s in 2015;5;27
Things to Do in Connecticut, Jan. 30 Through Feb. 7;1;29
For Some Diabetics, a Struggle to Pay for Insulin;2;29
